Galecto Raises $64 Million to Accelerate Development of Clinical Pipeline

by Ysios Capital

Funds will support preparations for potential EU conditional approval of GB0139 in IPF and multiple new Phase 2 clinical trials

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

Sustancias presentes en algunos producto...

by Instituto de Investigación Biosanitaria - Ibs Granada

​El uso de algunos productos cosméticos y de cuidado personal (como...

Photos Stream